SCHEMBL4916915

SCHEMBL4916915

COc1cccc(F)c1CNCc1ccc(C(=O)NO)cc1

nearest known ligand 0.59

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ HDAC1 Q13547 13/20 0.59
▸ KMT2A Q03164 4/20 0.57
▸ MEN1 O00255 2/20 0.57
▸ HDAC8 Q9BY41 8/20 0.56
▸ HDAC2 Q92769 3/20 0.56
▸ HDAC3 O15379 2/20 0.56
▸ HDAC6 Q9UBN7 9/20 0.55
▸ HDAC11 Q96DB2 2/20 0.53
▸ HDAC4 P56524 1/20 0.51
▸ HDAC7 Q8WUI4 1/20 0.51
▸ HDAC10 Q969S8 1/20 0.51
▸ HDAC9 Q9UKV0 1/20 0.51
▸ HDAC5 Q9UQL6 1/20 0.51
▸ KDM4E B2RXH2 1/20 0.46
▸ NPC1 O15118 1/20 0.46
▸ CASP3 P42574 1/20 0.46
▸ RAB9A P51151 1/20 0.46
▸ SENP7 Q9BQF6 1/20 0.46
▸ KDM1A O60341 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4925838 0.86 HDAC1 (0.60) HDAC1KMT2AHDAC8HDAC2HDAC3
SCHEMBL4925731 0.73 HDAC6 (0.58) HDAC1KMT2AMEN1HDAC8HDAC2
SCHEMBL30690059 0.73 HDAC6 (0.73) HDAC1HDAC8HDAC2HDAC3HDAC6
SCHEMBL4927482 0.71 HDAC6 (0.65) HDAC1HDAC8HDAC2HDAC3HDAC6
SCHEMBL27891607 0.70 HDAC1 (0.55) HDAC1HDAC8HDAC2HDAC3HDAC6
SCHEMBL6989383 0.70 KMT2A (0.59) HDAC1KMT2AMEN1HDAC8HDAC2
SCHEMBL15289681 0.69 HDAC1 (1.00) HDAC1KMT2AMEN1HDAC8HDAC2
SCHEMBL28025063 0.69 HDAC1 (0.63) HDAC1HDAC8HDAC2HDAC3HDAC6
SCHEMBL13408002 0.69 KDM1A (0.54) KMT2AMEN1KDM4EKDM1A
SCHEMBL22807323 0.68 SMN1; SMN2 (0.50) KMT2AMEN1NPC1KDM1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080269282-A1 Compounds for Inhibiting Copper-Containing Amine Oxidases and Uses Thereof GENMEDICA THERAPEUTICS SL (ES) 2008-10-30 — — US disclosed
US-20070066646-A1 Compounds for Inhibiting Copper-Containing Amine Oxidases and Uses Thereof GENMEDICA THERAPEUTICS SL (ES) 2007-03-22 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080269282-A1 Compounds for Inhibiting Copper-Containing Amine Oxidases and Uses Thereof AOC2, AOC3, AOC1 HDAC1 563/4885KMT2A 3374/4885MEN1 1562/4885
US-20070066646-A1 Compounds for Inhibiting Copper-Containing Amine Oxidases and Uses Thereof AOC2, AOC3, AOC1 HDAC1 622/4885KMT2A 3243/4885MEN1 1683/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback